指南与共识胸部CT

最佳实践:国际多学会关于COVID-19后胸部CT残留异常的共识声明

Best Practice: International Multisociety Consensus Statement for Post-COVID-19 Residual Abnormalities on Chest CT Scans.
指南 / 共识 · Radiology · 2025-01-01

该多学会共识由欧洲胸部影像学会、胸部放射学会和亚洲胸部放射学会的21名胸部放射学家通过两轮调查制定,旨在规范COVID-19后残留肺部异常的CT检查指征、采集和报告。关键推荐包括:感染后3个月持续或进展性呼吸道症状者行胸部CT,随访采用低剂量CT协议(范围1-3 mSv),使用Fleischner学会术语表描述影像,避免使用「间质性肺异常」一词,改用「COVID-19后残留肺部异常」。

要点

  • 感染后3个月持续或进展性呼吸道症状者推荐行胸部CT。
  • 随访胸部CT推荐采用低剂量CT协议(范围1-3 mSv)。
  • 描述影像使用Fleischner学会术语表,避免使用「间质性肺异常」。

核心结论

  • COVID-19后残留肺部异常在CT上倾向于随时间稳定或消退,表明其非进展性和感染后性质;共识旨在标准化CT指征、采集和报告,以协调放射学实践和研究。

研究设计与样本

  • 国际多学会共识声明,由欧洲胸部影像学会、胸部放射学会和亚洲胸部放射学会的21名胸部放射学家通过两轮调查过程制定。

关键影像表现/征象

  • COVID-19呼吸道感染后CT上的残留肺部异常可能与持续或进展性呼吸道症状相关,并常与肺功能检查异常相关。
  • COVID-19感染后胸部CT肺部异常倾向于随时间稳定或消退。

诊断标准与关键数值

  • 推荐对感染后3个月有持续或进展性呼吸道症状的患者行胸部CT。
  • 随访胸部CT检查使用低剂量CT协议(范围,1-3 mSv)。
  • 使用Fleischner学会术语表描述影像。
  • 避免使用「间质性肺异常」一词描述COVID-19后异常,改用「COVID-19后残留肺部异常」以防止误认为间质性肺病的早期表现。

临床应用与阅片要点

  • 对感染后3个月有持续或进展性呼吸道症状的患者行胸部CT。
  • 随访胸部CT采用低剂量CT协议(范围,1-3 mSv)。
  • 报告中使用Fleischner学会术语表描述影像。
  • 避免使用「间质性肺异常」一词,使用「COVID-19后残留肺部异常」。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Residual lung abnormalities on CT scans after COVID-19 respiratory infection may be associated with persistent or progressive respiratory symptoms and frequently correlate with abnormal pulmonary function testing results. These abnormalities have been described using varying terms in numerous publications. Chest CT lung abnormalities after COVID-19 infection tend to stabilize or regress over time, indicating that they are nonprogressive and postinfectious in nature. This multisociety consensus statement, developed by 21 thoracic radiologists from the European Society of Thoracic Imaging, the Society of Thoracic Radiology, and the Asian Society of Thoracic Radiology with a two-round survey process, aims to standardize the indication, acquisition, and reporting of post-COVID-19 residual lung abnormalities on CT scans. Key recommendations include performing chest CT in patients with persistent or progressive respiratory symptoms 3 months after infection, using low-dose CT protocols (range, 1-3 mSv) for follow-up chest CT examinations, using Fleischner Society glossary of terms for radiologic descriptors, and avoiding the term interstitial lung abnormality to describe post-COVID-19 abnormalities. Instead, to prevent misinterpreting post-COVID-19 abnormalities as an early manifestation of interstitial lung disease, use the term post-COVID-19 residual lung abnormality. This consensus statement will help harmonize radiology practice and research for the substantial number of affected patients.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Yoon SH, Kanne JP, Ashizawa K, et al. Best Practice: International Multisociety Consensus Statement for Post-COVID-19 Residual Abnormalities on Chest CT Scans. Radiology. 2025. PMID: 40693930. doi:10.1148/radiol.243374

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。